A prospective, non-randomized Roentgen Stereophotogrammetric Analysis study of the Stryker Accolade II(R) Hip Stem
- Conditions
- Osteoarthritis of the hipMusculoskeletal - OsteoarthritisSurgery - Surgical techniques
- Registration Number
- ACTRN12611000954921
- Lead Sponsor
- Stryker Australia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 35
1. The patient is a male or non-pregnant female between the ages of 20-80.
2. The patient is a candidate for a primary cementless total hip replacement using the study devices.
3. The patient has a primary diagnosis of non-inflammatory degenerative joint disease, including osteoarthritis and avascular necrosis.
4. The patient has signed the study specific, HREC-approved, Informed Consent document.
5. The patient is willing and able to comply with the specified pre-operative and post-operative clinical and radiographic evaluations.
1. Patients with active infection within the affected hip joint.
2. Patients requiring revision surgery of a previously implanted total hip arthroplasty or hip fusion to the affected joint.
3. The patient is obese (BMI >= 40).
4. The patient has a neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.
5. The patient has a systemic or metabolic disorder leading to progressive bone deterioration.
6. The patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements.
7. Patient has a cognitive impairment, an intellectual disability or a mental illness.
8. The patient is pregnant.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the migration pattern (translations and rotations) of the Accolade II(R) stem during the first 2 years post-surgery. This will be assessed via measurement on x-rays of any micromotion of tantalum bead markers that were inserted at the time of surgery.[Pre-operative<br>Intra-operative<br>Post-Operative - 3 months<br>Post-Operative - 6 months<br>Post-operative - 12 months<br>Post-operative - 24 months]
- Secondary Outcome Measures
Name Time Method